Skip to Main Content

Author Details

David A Wohl
The University of North Carolina School of Medicine
1997
235
46
PMIDPaper TitleJournal TitlePublished Year
38051788The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy.AIDS2024
36344644The Impact of Discharge Against Medical Advice on Readmission After Opioid Use Disorder-Associated Infective Endocarditis: a National Cohort Study.J Gen Intern Med2023
37745410Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.bioRxiv2023
37650237Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.J Infect Dis2023
37650236Long COVID After Bamlanivimab Treatment.J Infect Dis2023
37650234Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.J Infect Dis2023
37650232Immune Status and SARS-CoV-2 Viral Dynamics.J Infect Dis2023
37650233Variant-Specific Viral Kinetics in Acute COVID-19.J Infect Dis2023
37650231ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.J Infect Dis2023
37650230Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.J Infect Dis2023
38096455"What Is the Benefit?": Perceptions and Preferences for Long-Acting Injectable Antiretroviral Therapy Among People Living With HIV.AIDS Educ Prev2023
37279602One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.Clin Infect Dis2023
37004887Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial.Gastroenterology2023
36972208It takes more than a machine: A pilot feasibility study of point-of-care HIV-1 viral load testing at a lower-level health center in rural western Uganda.PLOS Glob Public Health2023
37099295Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials.JAMA Netw Open2023
37200995Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.EClinicalMedicine2023
37068272Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.Ann Intern Med2023
37096642Standing-up COVID-19 monoclonal antibody infusion centers: Infection prevention and control.Am J Infect Control2023
36996258A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.PLoS One2023
36920412Long-term success for people living with HIV: A framework to guide practice.HIV Med2023
36920411Why we need to re-define long-term success for people living with HIV.HIV Med2023
36802755Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.Ann Intern Med2023
36601684Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials.Clin Transl Sci2023
36661240Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.J Infect Dis2023
36658128Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.Nat Commun2023
36210483Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019.Clin Infect Dis2023
36065768Post-Ebola Symptoms 7 Years After Infection: The Natural History of Long Ebola.Clin Infect Dis2023
34596223Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort.Clin Infect Dis2022
35709970Reduction and persistence of co-circulating respiratory viruses during the SARS-CoV-2 pandemic.Am J Infect Control2022
35797235Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 Infection.Clin Pharmacol Ther2022
35793677Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection.Cell Rep Med2022
35850699The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone.BMC Infect Dis2022
37008801A longitudinal study of olfactory dysfunction and parosmia in mild COVID-19 cases.Rhinol Online2022
36480499Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center.PLoS One2022
36467293Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19.Open Forum Infect Dis2022
36411792COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelines.ERJ Open Res2022
35935279Antimicrobial-resistant Enterobacterales colonization in people with HIV.JAC Antimicrob Resist2022
35996832A systematic review of whether COVID-19 randomized controlled trials reported on demographic and clinical characteristics.Pharmacoepidemiol Drug Saf2022
35995785Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.Nat Commun2022
36225740Predicting Risk of Multidrug-Resistant Enterobacterales Infections Among People With HIV.Open Forum Infect Dis2022
35982660Viral and Symptom Rebound in Untreated COVID-19 Infection.medRxiv2022
36378539Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses.JCI Insight2022
36119962Dying at Home Due to Coronavirus Disease 2019.Open Forum Infect Dis2022
34941423A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.Sci Transl Med2022
35298899Inequities in access to diagnostics threatens global public health security.Lancet Infect Dis2022
35022711Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.Clin Infect Dis2022
34383889Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in the United States: Living Density, Viral Load, and Disproportionate Impact on Communities of Color.Clin Infect Dis2022
34643220Resistance in Enterobacterales Is Higher Among People Living With Human Immunodeficiency Virus.Clin Infect Dis2022
33397765Spotlight on the Safety Net: Deploying Mobile COVID-19 Testing Programs in North Carolina as an Approach to Improving Health Equity.N C Med J2021
33822010Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone.Clin Infect Dis2021
  • 1 - 50 of 235

Recommended Authors

Jennifer O Lam
Kaiser Permanente Northern California
Career Start Year 2012
Number of shared co-authors 4
Sara H Bares
University of Nebraska Medical Center
Career Start Year 2011
Number of shared co-authors 2
Katherine R Schafer
Wake Forest School of Medicine, University of North Carolina
Career Start Year 2010
Number of shared co-authors 2
Cathy A Jenkins
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 6
Allison DeLong
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 3
Maggie Czarnogorski
7 George Washington University
Career Start Year 2004
Number of shared co-authors 2
Vincent Lo Re
IRCCS-ISMETT
Career Start Year 2001
Number of shared co-authors 11
Edward J Mills
McMaster University
Career Start Year 2001
Number of shared co-authors 10
Robert Gross
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 6
Tassos C Kyriakides
Yale School of Public Health
Career Start Year 1999
Number of shared co-authors 0
Sonia Jain
University of California San Diego
Career Start Year 1997
Number of shared co-authors 1
Rochelle P Walensky
Massachusetts General Hospital
Career Start Year 1996
Number of shared co-authors 6
Laura Smeaton
Harvard TH Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 8
Charles B Hare
Kaiser Permanente San Francisco Medical Center
Career Start Year 1994
Number of shared co-authors 3
Gregory D Kirk
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1993
Number of shared co-authors 14
Raphael J Landovitz
university of california los angeles Center for Clinical AIDS Research & Education
Career Start Year 1992
Number of shared co-authors 9
Todd Hulgan
Vanderbilt University Medical Center
Career Start Year 1992
Number of shared co-authors 8
Roger Paredes
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 9
Patrick S Sullivan
Rollins School of Public Health, Emory University
Career Start Year 1990
Number of shared co-authors 8
David R Holtgrave
University of Pennsylvania
Career Start Year 1989
Number of shared co-authors 2
Steven G Deeks
University of California san francisco
Career Start Year 1988
Number of shared co-authors 25
Amy C Justice
VA Connecticut Healthcare System
Career Start Year 1988
Number of shared co-authors 16
Jason Leider
Jacobi Medical Center
Career Start Year 1986
Number of shared co-authors 0
Virginia L Kan
VA Medical Center
Career Start Year 1986
Number of shared co-authors 2
Merceditas Villanueva
Yale University
Career Start Year 1984
Number of shared co-authors 1
Matthew Bidwell Goetz
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 5
Barbara Gripshover
Case Western Reserve University
Career Start Year 1981
Number of shared co-authors 4
Florin Vaida
School of Public Health, university of california san diego
Career Start Year 1980
Number of shared co-authors 3
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 11
Dushyantha Jayaweera
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 6

Collaborators

Joseph J Eron
Co-authored papers 44
William A Fischer
University of North Carolina School of Medicine
Co-authored papers 35
Judith S Currier
David Geffen School of Medicine, University of California los angeles
Co-authored papers 27
Eric S Daar
Co-authored papers 25
Paul E Sax
Co-authored papers 13
Edwin DeJesus
Co-authored papers 12
Alexander L Greninger
University of Washington Medical Center
Co-authored papers 10
Jos?? R Arribas
La Paz University Hospital
Co-authored papers 9
Claire E Farel
Co-authored papers 8
Pablo Tebas
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 8
Davey M Smith
University of California San Diego
Co-authored papers 7
Joel E Gallant
Co-authored papers 6
John S Schieffelin
Tulane University
Co-authored papers 6
Amanda Clarke
Co-authored papers 6
Adriana Weinberg
Co-authored papers 6
Cecilia M Shikuma
Co-authored papers 5
Ralph S Baric
University of North Carolina
Co-authored papers 5
Jeffrey M Jacobson
Co-authored papers 4
Carl J Fichtenbaum
University of Cincinnati
Co-authored papers 4
Richard Haubrich
Co-authored papers 4
Daniel R Kuritzkes
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 4
Sharon Parker
North Carolina Agricultural and Technical State University
Co-authored papers 3
Prema Menezes
Co-authored papers 3
Hans-Jürgen Stellbrink
Co-authored papers 3
Giovanni Guaraldi
University Hospital of Modena Policlinico, University of Modena and Reggio Emilia
Co-authored papers 2
Emily W Gower
University of North Carolina at Chapel Hill
Co-authored papers 2
Robert F Garry
Tulane University School of Medicine
Co-authored papers 2
Ian Crozier
Christchurch Hospital
Co-authored papers 2
Ian Frank
IF School of Medicine, University of Pennsylvania
Co-authored papers 2
Janet Andersen
Harvard School of Public Health
Co-authored papers 2
Release 1.2